Hormonal
Continued treatment with Tirzepatide maintains significant weight loss and cardiometabolic improvements, whereas discontinuation leads to partial weight regain and loss of benefits, demonstrating that long-term adherence is required to sustain outcomes.
If you are using Tirzepatide for weight loss, understand that it is a long-term treatment, not a short-term fix. Stopping the medication will likely cause you to regain most of the weight you lost. To keep the weight off, you must continue the medication indefinitely, combined with healthy lifestyle habits, just as you would manage high blood pressure with medication.
Those who discontinued tirzepatide regained weight to a mean of 97.0 kg whereas those who continued to take the drug achieved a mean weight of 79.1 kg... the slope appeared to continue to rise and given enough time would probably get back to baseline eventually.
Why this rating
Based on a Phase 3 randomized controlled trial (SURMOUNT-4) with a large sample size (n=783) and long duration (88 weeks), though presented as an abstract/presentation summary rather than full peer-reviewed text.
Source
Tirzepatide maintained significant weight loss when treatment was continued in a follow‐up study
Iskandar Idris · Diabetes Obesity and Metabolism Now · 2023
DOI 10.1002/doi2.79
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →